Dialysis News and Research

Latest Dialysis News and Research

DaVita recognized as one of FORTUNE Magazine’s Most Admired Companies in 2010

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), has been recognized as one of FORTUNE Magazine’s Most Admired Companies in 2010 for the fifth consecutive year.

11 Mar 2010

Rex Medical receives FDA Clearance for Cleaner Rotational Thrombectomy System

Rex Medical, L.P., today announced that it has received 510(k) Clearance from the U.S. Food and Drug Administration for the Cleaner™ Rotational Thrombectomy System. Cleaner™ technology is indicated for mechanical declotting of occluded native vessel dialysis fistulae and synthetic dialysis access grafts.

11 Mar 2010

Poor, minority adults with chronic kidney disease face increase risk of developing ESRD

Chronic kidney disease (CKD) afflicts a large number of younger minority adults receiving medical care in settings that serve the uninsured and underinsured (settings collectively known as the healthcare safety net). Poor, minority adults with moderate to severe CKD are also two to four times more likely to progress to kidney failure than non-Hispanic whites.

11 Mar 2010

Argon Medical Devices, Rex Medical announce licensing agreement for Cleaner Rotational Thrombectomy System

Argon Medical Devices, Inc. announced today that it has entered into a definitive licensing agreement with privately held Rex Medical, LP for exclusive rights to market and distribute the Cleaner™ Rotational Thrombectomy System in the United States, European Union and Canada. Cleaner is a medical device designed for the mechanical declotting of occluded native vessel dialysis fistulae and synthetic dialysis access grafts.

10 Mar 2010

Bristol-Myers Squibb, AstraZeneca commence SAVOR-TIMI 53 trial of ONGLYZA for type 2 diabetes

Bristol-Myers Squibb Company and AstraZeneca today announced the commencement of the “Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus” trial, a multicenter, randomized, double-blind, placebo-controlled Phase 4 study, to evaluate treatment with ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 inhibitor, in adult type 2 diabetes patients with cardiovascular risk factors.

10 Mar 2010

Cantel Medical's fiscal 2010 second-quarter net income up 29%

CANTEL MEDICAL CORP. reported a 29% increase in net income to $4,876,000, or $0.29 per diluted share, on a 6.7% increase in sales to $66,587,000 for the second quarter ended January 31, 2010. This compares with net income of $3,774,000, or $0.23 per diluted share, on sales of $62,420,000 for the second quarter ended January 31, 2009.

9 Mar 2010

Tracking kidney number is just as important as controlling cholesterol, say DNA physicians

It's a silent epidemic that affects millions of Americans. Chronic Kidney Disease (CKD) is a life-threatening illness that can often be treated successfully if found early, and can be detected at an early stage using simple, inexpensive blood and urine tests. As part of its 2010 World Kidney Day awareness program, the physicians of Dallas Nephrology Associates urge everyone to know and track their "kidney number."

9 Mar 2010

Positive interim results from NxStage Medical's FREEDOM study in RLS

NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today announced the latest interim results from its ongoing FREEDOM study, which show the significant improvement of overall sleep quality and marked improvement in Restless Legs Syndrome (RLS) experienced by patients after four months of daily home hemodialysis therapy with the NxStage System One™.

8 Mar 2010

DaVita's presentations at ADC: New developments in the field of CKD, Vascular Access and Home Modalities

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), in conjunction with DaVita Clinical Research®, today announced that company representatives will present 20 presentations at the 30th Annual Dialysis Conference scheduled for March 6 – 9 in Seattle.

8 Mar 2010

Acologix presents preclinical study results of AC-100 on cartilage regeneration at ORS annual meeting

Acologix, Inc., a privately held biopharmaceutical company, today announced the results of its latest preclinical study demonstrating that AC-100, its therapeutic product candidate derived from an endogenous human protein, promotes cartilage regeneration in a large animal model. The data will be presented by Dr. David M. Rosen on March 6, 2010 at the 56th annual meeting of the ORS in New Orleans, LA.

8 Mar 2010

PADF and OAS seek donations for Chilean relief and children's clinics

Donations are requested for Chilean relief and to help a group of specialized children's clinics that were damaged by the earthquake and aftershocks, the non-profit Pan American Development Foundation (PADF) and the Organization of American States (OAS) announced.

6 Mar 2010

Dialysis patients gather to encourage state lawmakers to support Medigap legislation

More than 50 dialysis patients, family members and kidney care advocates from across South Carolina gathered at the state Capitol today with the National Kidney Foundation Serving the Carolinas, South Carolina Region (NKF) and Dialysis Patient Citizens (DPC) to encourage state lawmakers to support Medigap legislation (S. 1128, sponsored by Senators Harvey Peeler (R-Cherokee) and Phillip Shoopman (R-Greenville), and H. 4552, sponsored by Representatives Joan Brady (R-Richland), Bill Sandifer (R-Seneca) and Kristopher Crawford (R-Florence)).

5 Mar 2010

U.S. Vascular Access Holdings acquires National Vascular Care

Fresenius Medical Care, the world’s largest provider of dialysis services and products, today announced that its subsidiary, U.S. Vascular Access Holdings, LLC has completed the acquisition of National Vascular Care Inc.

4 Mar 2010

Diplomat Specialty Pharmacy to help patients obtain financial assistance to purchase life-saving drugs

Diplomat Specialty Pharmacy, the nation's largest privately held specialty pharmacy company, is on a mission to help patients obtain the financial assistance they need to purchase life-saving drugs for such illnesses as cancer, HIV/AIDS and Hepatitis C, as well as drugs for Multiple Sclerosis, kidney disease and other chronic conditions.

4 Mar 2010

South Carolina kidney patients to meet lawmakers and urge passage of S. 1128 legislation

On Wednesday, March 3, kidney patients from across South Carolina will join the National Kidney Foundation Serving the Carolinas, South Carolina Region and Dialysis Patient Citizens in holding a briefing at the State Capitol Rotunda, followed by a series of meetings with lawmakers and staff, urging the passage of key legislation this year that would help approximately 500 South Carolina kidney failure patients and thousands of disabled South Carolinians who are struggling to access health insurance for the life-saving medical care they need.

3 Mar 2010

athenahealth, DaVita to deliver web-based EHR and revenue cycle management service to nephrologists

athenahealth, Inc., a leading provider of internet-based business services to physician practices, and DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), announced a partnership to deliver an integrated, web-based electronic health record (EHR) and revenue cycle management service to nephrologists across the country.

3 Mar 2010

Merck’s MF/F Phase III study data presented at AAAAI annual meeting

Data from two Phase III studies of Merck’s investigational fixed-dose combinations of mometasone furoate and formoterol fumarate (MF/F) were presented by researchers today in two poster presentations at the American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting.

3 Mar 2010

Greater use of ESAs and iron at lower hematocrit levels decrease risk of death for hemodialysis patients

Greater use of erythropoiesis-stimulating agents (ESAs) and more frequent use of iron at lower hematocrit levels (the proportion of the blood that consists of red blood cells) was associated with a decreased risk of death for hemodialysis patients, according to a study in the March 3 issue of JAMA.

3 Mar 2010

Aggressive treatment of anemia with ESAs may lower risk of death for dialysis patients: Study

Aggressive treatment of anemia with intravenous iron and drugs known as erythropoiesis-stimulating agents (ESAs) may lower the risk of death for dialysis patients with severe anemia - but also may increase the risk of death among patients with milder anemia, a new study led by a University of North Carolina at Chapel Hill epidemiologist suggests.

3 Mar 2010

Baxter Healthcare's IIPV product recall of HomeChoice peritoneal dialysis cyclers classified as Class I recall

Baxter Healthcare Corporation announced today that the U.S. Food and Drug Administration (FDA) has classified Baxter’s recent Urgent Product Recall regarding Increased Intraperitoneal Volume (IIPV), or overfill of the abdominal cavity, associated with HomeChoice and HomeChoice Pro peritoneal dialysis cyclers as a Class I recall.

From Baxter International Inc. 3 Mar 2010

Dialysis News and Research

Latest Dialysis News and Research

DaVita recognized as one of FORTUNE Magazine’s Most Admired Companies in 2010

Rex Medical receives FDA Clearance for Cleaner Rotational Thrombectomy System

Poor, minority adults with chronic kidney disease face increase risk of developing ESRD

Argon Medical Devices, Rex Medical announce licensing agreement for Cleaner Rotational Thrombectomy System

Bristol-Myers Squibb, AstraZeneca commence SAVOR-TIMI 53 trial of ONGLYZA for type 2 diabetes

Cantel Medical's fiscal 2010 second-quarter net income up 29%

Tracking kidney number is just as important as controlling cholesterol, say DNA physicians

Positive interim results from NxStage Medical's FREEDOM study in RLS

DaVita's presentations at ADC: New developments in the field of CKD, Vascular Access and Home Modalities

Acologix presents preclinical study results of AC-100 on cartilage regeneration at ORS annual meeting

PADF and OAS seek donations for Chilean relief and children's clinics

Dialysis patients gather to encourage state lawmakers to support Medigap legislation

U.S. Vascular Access Holdings acquires National Vascular Care

Diplomat Specialty Pharmacy to help patients obtain financial assistance to purchase life-saving drugs

South Carolina kidney patients to meet lawmakers and urge passage of S. 1128 legislation

athenahealth, DaVita to deliver web-based EHR and revenue cycle management service to nephrologists

Merck’s MF/F Phase III study data presented at AAAAI annual meeting

Greater use of ESAs and iron at lower hematocrit levels decrease risk of death for hemodialysis patients

Aggressive treatment of anemia with ESAs may lower risk of death for dialysis patients: Study

Baxter Healthcare's IIPV product recall of HomeChoice peritoneal dialysis cyclers classified as Class I recall

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Dialysis News and Research

Latest Dialysis News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in